1 Min Read
Nov 15 (Reuters) - Critical Outcome Technologies Inc
* Critical Outcome Technologies announces pharmacokinetic data from phase 1 dose escalation portion of COTI-2 trial in gynecological malignancies Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.